期刊
CURRENT PSYCHIATRY REPORTS
卷 19, 期 6, 页码 -出版社
SPRINGER
DOI: 10.1007/s11920-017-0783-9
关键词
Methadone; Buprenorphine; Naltrexone; Pharmacotherapy for opioid use disorder; Barriers to drug abuse treatment
类别
资金
- National Institute on Drug Abuse (NIDA) [2U01DA013636]
Purpose of Review The recent heroin and prescription opioid misuse epidemic has led to a sharp increase in the number of opioid overdose deaths in the USA. Notwithstanding the availability of three FDA-approved medications (methadone, buprenorphine, and naltrexone) to treat opioid use disorder, these medications are underutilized. This paper provides an update from the recent peer-reviewed literature on barriers to the use of these medications. Findings These barriers are interrelated and can be categorized as financial, regulatory, geographic, attitudinal, and logistic. While financial barriers are common to all three medications, other barriers are medicationspecific. Summary The adverse impact of the current opioid epidemic on public health can be reduced by increasing access to effective pharmacotherapy for opioid use disorder.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据